Correlation Between GenMont Biotech and Medigen Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GenMont Biotech and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GenMont Biotech and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GenMont Biotech and Medigen Biotechnology, you can compare the effects of market volatilities on GenMont Biotech and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GenMont Biotech with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GenMont Biotech and Medigen Biotechnology.

Diversification Opportunities for GenMont Biotech and Medigen Biotechnology

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between GenMont and Medigen is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding GenMont Biotech and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and GenMont Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GenMont Biotech are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of GenMont Biotech i.e., GenMont Biotech and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between GenMont Biotech and Medigen Biotechnology

Assuming the 90 days trading horizon GenMont Biotech is expected to generate 0.65 times more return on investment than Medigen Biotechnology. However, GenMont Biotech is 1.53 times less risky than Medigen Biotechnology. It trades about -0.27 of its potential returns per unit of risk. Medigen Biotechnology is currently generating about -0.19 per unit of risk. If you would invest  2,290  in GenMont Biotech on September 24, 2024 and sell it today you would lose (330.00) from holding GenMont Biotech or give up 14.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy98.46%
ValuesDaily Returns

GenMont Biotech  vs.  Medigen Biotechnology

 Performance 
       Timeline  
GenMont Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GenMont Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

GenMont Biotech and Medigen Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GenMont Biotech and Medigen Biotechnology

The main advantage of trading using opposite GenMont Biotech and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GenMont Biotech position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.
The idea behind GenMont Biotech and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments